Characterization of the immune response in patients with urothelial cell carcinoma of the bladder and during the BCG immunotherapy of bladder cancer
- Conditions
- C67Malignant neoplasm of bladder
- Registration Number
- DRKS00003700
- Lead Sponsor
- Chirurgische Universitätsklinik, Abteilung für Urologie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 410
Inclusion Criteria
All patients undergoing treatment for urothelial cancer in the urologic department
Exclusion Criteria
Patients with compromised immune status, eg. AIDS, aquired immunodeficiency
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Identification of a serological marker for bladder cancer
- Secondary Outcome Measures
Name Time Method